DK0590531T3 - Antithrombin III-præparat - Google Patents

Antithrombin III-præparat

Info

Publication number
DK0590531T3
DK0590531T3 DK93115422T DK93115422T DK0590531T3 DK 0590531 T3 DK0590531 T3 DK 0590531T3 DK 93115422 T DK93115422 T DK 93115422T DK 93115422 T DK93115422 T DK 93115422T DK 0590531 T3 DK0590531 T3 DK 0590531T3
Authority
DK
Denmark
Prior art keywords
antithrombin iii
powder
iii preparation
solvent
alkyl ester
Prior art date
Application number
DK93115422T
Other languages
Danish (da)
English (en)
Inventor
Toshinobu Aoyama
Keizou Hirahara
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17402131&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0590531(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of DK0590531T3 publication Critical patent/DK0590531T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93115422T 1992-10-02 1993-09-24 Antithrombin III-præparat DK0590531T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26436492A JP3494667B2 (ja) 1992-10-02 1992-10-02 アンチトロンビンｉｉｉ製剤

Publications (1)

Publication Number Publication Date
DK0590531T3 true DK0590531T3 (da) 2000-06-13

Family

ID=17402131

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93115422T DK0590531T3 (da) 1992-10-02 1993-09-24 Antithrombin III-præparat

Country Status (12)

Country Link
US (1) US5385890A (fr)
EP (1) EP0590531B1 (fr)
JP (1) JP3494667B2 (fr)
KR (1) KR100264707B1 (fr)
AT (1) ATE188385T1 (fr)
AU (1) AU672430B2 (fr)
CA (1) CA2107516C (fr)
DE (1) DE69327498T2 (fr)
DK (1) DK0590531T3 (fr)
ES (1) ES2141123T3 (fr)
GR (1) GR3032580T3 (fr)
PT (1) PT590531E (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022471A1 (fr) * 1993-04-05 1994-10-13 The Green Cross Corporation Preparation liquide d'antithrombine iii et procede pour sa stabilisation
AT405905B (de) * 1997-03-25 1999-12-27 Immuno Ag Neue verwendung von antithrombin iii
US6518406B1 (en) * 1999-06-23 2003-02-11 Octapharma Ag Method for purification of proteins
CN114813287A (zh) * 2022-06-29 2022-07-29 深圳市帝迈生物技术有限公司 一种用于肝素抗凝检测的校准品及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
US5319072A (en) * 1992-01-10 1994-06-07 Alpha Therapeutic Corporation Human antithrombin-III preparation

Also Published As

Publication number Publication date
EP0590531B1 (fr) 2000-01-05
EP0590531A1 (fr) 1994-04-06
ES2141123T3 (es) 2000-03-16
US5385890A (en) 1995-01-31
GR3032580T3 (en) 2000-05-31
DE69327498D1 (de) 2000-02-10
ATE188385T1 (de) 2000-01-15
CA2107516A1 (fr) 1994-04-03
JPH06116167A (ja) 1994-04-26
PT590531E (pt) 2000-05-31
DE69327498T2 (de) 2000-06-08
AU672430B2 (en) 1996-10-03
JP3494667B2 (ja) 2004-02-09
AU4872893A (en) 1994-04-14
KR940008695A (ko) 1994-05-16
KR100264707B1 (ko) 2000-09-01
CA2107516C (fr) 2004-12-07

Similar Documents

Publication Publication Date Title
LV10907A (lv) Interferona polietilenglikola atvasinajums
DE69132006D1 (de) Thiazolederivate als inhibitoren von aktivem sauerstoff
DE3880047D1 (de) Zusammensetzung eines zusatzes.
JPS53119844A (en) Optically active amino acid-mandelic acid complexes and theire preparation
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
EP0341707A3 (en) Phenylethanol ester of ortho-cinnamic acid, its preparation and use as fragrance compound
BG36348A3 (en) Method for preparing thienopyridinon derivatives
DK0590531T3 (da) Antithrombin III-præparat
GR3021511T3 (en) Stable freeze dried polyhematoporphyrin ether/ester composition
IT8747701A0 (it) Composizioni stabili allo stoccaggio di assorbenti uv
ATE84209T1 (de) Hautreinigungsmittel.
BG35749A3 (en) Method for preparing 20- dihydro- 20, 23- dideoxytilonolide
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
ES2090835T3 (es) Calibrador y su uso en un ensayo inmunologico.
BG34454A3 (en) Method of obtaining derivatives of 7beta- aminothiazolylacetamido- 3- cephem -4-carbonic acid
DE2960291D1 (en) Coumarin derivatives and their use as brightening agents for high molecular organic substances
DK320589D0 (da) Fremgangsmaade til hindring af vaekst af aerobe fungi i vandige carbonhydrider
ATE73812T1 (de) Thionophosphonsaeureester.
JPS53119819A (en) Substituted iso-valerianic acid and its ester
ZA916094B (en) Compositions containing phosphono compounds and organic acids as flameproofing agents
JPS53111080A (en) 2-phenyl-4h-1,3-thiazine derivative, its preparation and use
BG38335A3 (en) Method for preparing 1- etoxycarbonyloxyethylic ester of penicillin g
ATE21381T1 (de) Stabilisierte zusammensetzungen von 1,1,1trichlor|than.
JPS56139539A (en) Plasticizer for acetylcellulose
JPS535135A (en) 2-cyano-3-methyl-3-(4-isobutylphenyl)glycidic acid and its esters and their preparation